Skip to main content

7 Result(s)

within N-Y Hsu Remove this filter

and

  1. Article

    Erratum: FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction

    Correction to: Oncogene (2015) 34, 2505−2515; doi:10.1038/onc.2014.184; published online 7 July 2014 Since the publication of the above article, the authors have noticed that the PUMA immunostainings in the ‘A...

    D-W Wu, M-C Lee, N-Y Hsu, T-C Wu, J-Y Wu, Y-C Wang, Y-W Cheng, C-Y Chen, H Lee in Oncogene (2017)

    Download PDF (945 KB) View Article

  2. Article

    Erratum: FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction

    Correction to: Oncogene (2015) 34, 2505–2515; doi:10.1038/onc.2014.184; published online 7 July 2014 Since the publication of the above paper, the authors found a misplacing band in Figure 2e. The correct vers...

    D-W Wu, M-C Lee, N-Y Hsu, T-C Wu, J-Y Wu, Y-C Wang, Y-W Cheng, C-Y Chen, H Lee in Oncogene (2015)

    Download PDF (299 KB) View Article

  3. Article

    Erratum: FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction

    Correction to: Oncogene (2015) 34, 2505–2515; doi:10.1038/onc.2014.184; published online 7 July 2014 Since the online publication of the above article, it has been noted that affiliation for M-C Lee was incorr...

    D-W Wu, M-C Lee, N-Y Hsu, T-C Wu, J-Y Wu, Y-C Wang, Y-W Cheng, C-Y Chen, H Lee in Oncogene (2015)

    Download PDF (86 KB) View Article

  4. No Access

    Article

    FHIT loss confers cisplatin resistance in lung cancer via the AKT/NF-κB/Slug-mediated PUMA reduction

    Fragile histidine triad (FHIT) loss by the two-hit mechanism of loss of heterozygosity and promoter hypermethylation commonly occurrs in non-small cell lung cancer (NSCLC) and may confer cisplatin resistance i...

    D-W Wu, M-C Lee, N-Y Hsu, T-C Wu, J-Y Wu, Y-C Wang, Y-W Cheng, C-Y Chen, H Lee in Oncogene (2015)

  5. No Access

    Article

    c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT

    The dual role of the microRNA-29 (miR-29) family in tumor progression and metastasis in solid tumors has been reported. Evidence for the role of miR-29 in tumor malignancy and its prognostic value in overall s...

    D-W Wu, N-Y Hsu, Y-C Wang, M-C Lee, Y-W Cheng, C-Y Chen, H Lee in Oncogene (2015)

  6. No Access

    Article

    Differential expression of Sonic hedgehog and Gli1 in hematological malignancies

    L-Y Bai, C-F Chiu, C-W Lin, N-Y Hsu, C-L Lin, W-J Lo, M-C Kao in Leukemia (2008)

  7. No Access

    Article

    Comparison of Chemotherapy Response with P-Glycoprotein, Multidrug Resistance-Related Protein-1, and Lung Resistance-Related Protein Expression in Untreated Small Cell Lung Cancer

    The aim of this study was to investigate the expression of P-glycoprotein (Pgp), multidrug resistance-related protein-1 (MRP1), and lung resistance-related protein (LRP) in response to chemotherapy in untreate...

    J.-J. Yeh, N.-Y. Hsu, W.-H. Hsu, C.-H. Tsai, C.-C. Lin, J.-A. Liang in Lung (2005)